Isoptin SR

This page contains recent news articles, when available, and an overview of Isoptin SR but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Ranbaxy's net profit increases 53% to Rs 7901mn  -  Jan 17, 2008
Bn. Marking the Company’s entry into the Authorized Generics (AG) space, the Company acquired Isoptin SR, a dermatology product from FSC Laboratories. Moneycontrol.com (press release),

India's Ranbaxy Laboratories to sell Isoptin SR in US  -  Jul 30, 2007
Forbes,...company Ranbaxy Laboratories Ltd said it has started the production and sale of its first authorised generic drug Isoptin SR (Verapamil Sit) in the US.

India Ranbaxy launches its first authorised generic  -  Jul 30, 2007
ReutersBO: Quote, Profile, Research) said on Monday it had launched its first authorised generic drug, Isoptin SR, in the US market, after an agreement with FSC

Par Pharmaceutical Reports Sales and Earnings for 2005 Feb 28, 2006
This includes the fourth-quarter charge of $5.8 million, after tax, related to Par's acquisition of the product registration to Isoptin SR. ... - MSN Money

Par Pharmaceutical Reports Sales and Earnings for 2005  Feb 28, 2006
...and a non-cash charge of $5.8 million, after tax, for the impairment of assets related to Par's acquisition of the product registration to Isoptin® SR. ... - Yahoo! News

Updates, advisories and surprises Feb 28, 2006
...were $25 million to divest FineTech and a non-cash $5.8 million for impairment of assets related to Par's acquisition of the product registration to Isoptin SR ... - Investor's Business Daily (subscription)

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com